CompletedPhase 3

Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

NCT02683746

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

GSK Investigational Site

Birmingham, Alabama, United States

+69 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2016-03-16
Enrollment: 308 participants
Sponsor: GlaxoSmithKline
Purpose: treatment

Locations (70)

GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SiteBirmingham, Alabama, United States
GSK Investigational SiteChandler, Arizona, United States
GSK Investigational SiteGlendale, Arizona, United States
GSK Investigational SitePhoenix, Arizona, United States
GSK Investigational SiteAnaheim, California, United States
GSK Investigational SiteCanyon Country, California, United States
GSK Investigational SiteChula Vista, California, United States
GSK Investigational SiteFresno, California, United States
GSK Investigational SiteLomita, California, United States
GSK Investigational SiteOceanside, California, United States
GSK Investigational SiteSacramento, California, United States
GSK Investigational SiteSan Diego, California, United States
GSK Investigational SiteSpring Valley, California, United States
GSK Investigational SiteTustin, California, United States
GSK Investigational SiteVan Nuys, California, United States
GSK Investigational SiteWalnut Creek, California, United States
GSK Investigational SiteLittleton, Colorado, United States
GSK Investigational SiteBradenton, Florida, United States
GSK Investigational SiteBrooksville, Florida, United States
GSK Investigational SiteClearwater, Florida, United States
GSK Investigational SiteFleming Island, Florida, United States
GSK Investigational SiteHallandale, Florida, United States
GSK Investigational SiteHialeah, Florida, United States
GSK Investigational SiteMiami, Florida, United States
GSK Investigational SiteMiami, Florida, United States
GSK Investigational SiteNew Port Richey, Florida, United States
GSK Investigational SiteOrlando, Florida, United States
GSK Investigational SiteSt. Petersburg, Florida, United States
GSK Investigational SiteConyers, Georgia, United States
GSK Investigational SiteSnellville, Georgia, United States
GSK Investigational SiteMeridian, Idaho, United States
GSK Investigational SiteChicago, Illinois, United States
GSK Investigational SiteElgin, Illinois, United States
GSK Investigational SiteEvansville, Indiana, United States
GSK Investigational SiteTopeka, Kansas, United States
GSK Investigational SiteLexington, Kentucky, United States
GSK Investigational SiteLake Charles, Louisiana, United States
GSK Investigational SiteNew Orleans, Louisiana, United States
GSK Investigational SiteKalamazoo, Michigan, United States
GSK Investigational SiteTroy, Michigan, United States
GSK Investigational SiteChesterfield, Missouri, United States
GSK Investigational SiteSt Louis, Missouri, United States
GSK Investigational SiteLas Vegas, Nevada, United States
GSK Investigational SiteAlbuquerque, New Mexico, United States
GSK Investigational SiteNew Hyde Park, New York, United States
GSK Investigational SiteGreensboro, North Carolina, United States
GSK Investigational SiteShelby, North Carolina, United States
GSK Investigational SiteColumbus, Ohio, United States
GSK Investigational SiteMaumee, Ohio, United States
GSK Investigational SiteNorwood, Ohio, United States
GSK Investigational SitePerrysburg, Ohio, United States
GSK Investigational SiteAltoona, Pennsylvania, United States
GSK Investigational SiteAnderson, South Carolina, United States
GSK Investigational SiteColumbia, South Carolina, United States
GSK Investigational SiteArlington, Texas, United States
GSK Investigational SiteDallas, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteHouston, Texas, United States
GSK Investigational SiteKaty, Texas, United States
GSK Investigational SitePharr, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteSan Antonio, Texas, United States
GSK Investigational SiteSchertz, Texas, United States
GSK Investigational SiteSpring, Texas, United States
GSK Investigational SiteMurray, Utah, United States
GSK Investigational SiteFederal Way, Washington, United States
GSK Investigational SiteSpokane, Washington, United States
GSK Investigational SiteTacoma, Washington, United States